Cargando…
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
Background: We have previously shown that alendronate, an amino-bisphosphonate, when reformulated in liposomes, can significantly enhance the efficacy of cytotoxic chemotherapies and help remodel the immunosuppressive tumor microenvironment towards an immune-permissive milieu resulting in increased...
Autores principales: | Islam, Md. Rakibul, Patel, Jalpa, Back, Patricia Ines, Shmeeda, Hilary, Adamsky, Konstantin, Yang, Hui, Alvarez, Carlos, Gabizon, Alberto A., La-Beck, Ninh M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461478/ https://www.ncbi.nlm.nih.gov/pubmed/36105861 http://dx.doi.org/10.7150/ntno.75045 |
Ejemplares similares
-
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023) -
Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model
por: Islam, Md. Rakibul, et al.
Publicado: (2023) -
An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.
por: Gokhale, P. C., et al.
Publicado: (1996) -
Pegylated liposomal-encapsulated doxorubicin in cutaneous composite lymphoma: A case report
por: Wollina, Uwe, et al.
Publicado: (2016) -
Targeting doxorubicin encapsulated in stealth liposomes to solid tumors by non thermal diode laser
por: Ghannam, Magdy M., et al.
Publicado: (2016)